Viral Vector Manufacturing Market worth $12.8 billion by 2028

The global viral vector and plasmid DNA manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast period of 2023 to 2028.

Related Keywords

United Kingdom ,Germany ,United States ,Japan ,Netherlands ,Belgium ,America ,Kaneka Eurogentec ,Market Research Publishers ,Thermo Fisher Scientific Inc ,Fujifilm ,Corporation Japan ,Lonza Group Ag Switzerland ,Catalent Inc ,Danaher Corporation ,Takara Bio Inc ,Vgxi Inc ,Genscript Biotech Corporation ,Bluebird Bio Inc ,Charles River Laboratories International Inc ,Viral Vector Manufacturing Market ,North America ,Sample Pages ,Lonza Group ,Thermo Fisher Scientific ,Charles River Laboratories International ,Wuxi Apptec ,Takara Bio ,Oxford Biomedica ,Precision Biosciences ,Bluebird Bio ,Waisman Biomanufacturing ,Plasmidfactory Gmbh ,Gene Therapy Catapult ,Altogen Biosystems ,